Hydralazine tablet labels and packages: Difference between revisions
(Created page with "__NOTOC__ {{Hydralazine}} {{CMG}}; {{AE}} {{AK}} <ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = HYDRALAZINE HYDROCHLORIDE TABLET [PLIVA INC.]...") |
No edit summary |
||
| Line 3: | Line 3: | ||
{{CMG}}; {{AE}} {{AK}} | {{CMG}}; {{AE}} {{AK}} | ||
==LABELS AND PACKAGES== | |||
PRINCIPAL DISPLAY PANEL | |||
{| | |||
| [[image:hydrq3.jpg|400px|thumb]] | |||
|} | |||
Hydralazine Hydrochloride Tablets USP 10 mg 100s Label Text | |||
<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = HYDRALAZINE HYDROCHLORIDE TABLET [PLIVA INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ddbbdb09-3202-42d7-bbb0-08331dde2f54 | publisher = | date = | accessdate = 10 March 2014 }}</ref> | NDC 50111-398-01 | ||
HydrALAZINE | |||
HYDROCHLORIDE | |||
Tablets USP | |||
10 mg | |||
Rx only | |||
100 TABLETS | |||
TEVA | |||
PRINCIPAL DISPLAY PANEL | |||
{| | |||
| [[image:hydra4.jpg|400px|thumb]] | |||
|} | |||
Hydralazine Hydrochloride Tablets USP 25 mg 100s Label Text | |||
NDC 50111-327-01 | |||
HydrALAZINE | |||
HYDROCHLORIDE | |||
Tablets USP | |||
25 mg | |||
Rx only | |||
100 TABLETS | |||
TEVA | |||
PRINCIPAL DISPLAY PANEL | |||
{| | |||
| [[image:hydra5.jpg|400px|thumb]] | |||
|} | |||
Hydralazine Hydrochloride Tablets USP 50 mg 100s Label Text | |||
NDC 50111-328-01 | |||
HydrALAZINE | |||
HYDROCHLORIDE | |||
Tablets USP | |||
50 mg | |||
Rx only | |||
100 TABLETS | |||
TEVA | |||
PRINCIPAL DISPLAY PANEL | |||
{| | |||
| [[image:hydra6.jpg|400px|thumb]] | |||
|} | |||
Hydralazine Hydrochloride Tablets USP 100 mg 100s Label Text | |||
NDC 50111-397-01 | |||
HydrALAZINE | |||
HYDROCHLORIDE | |||
Tablets USP | |||
100 mg | |||
Rx only | |||
100 TABLETS | |||
TEVA<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = HYDRALAZINE HYDROCHLORIDE TABLET [PLIVA INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ddbbdb09-3202-42d7-bbb0-08331dde2f54 | publisher = | date = | accessdate = 10 March 2014 }}</ref> | |||
==References== | ==References== | ||
Revision as of 21:54, 10 March 2014
| Hydralazine |
|---|
| HYDRALAZINE tablet® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| HYDRALAZINE injection® FDA Package Insert |
| Indications and Usage |
| Dosage and Administration |
| Contraindications |
| Warnings |
| Precautions |
| Adverse Reactions |
| Drug Interactions |
| Use in Specific Populations |
| Overdosage |
| Description |
| Clinical Pharmacology |
| Nonclinical Toxicology |
| How Supplied/Storage and Handling |
| Labels and Packages |
| Clinical Trials on Hydralazine |
| ClinicalTrials.gov |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
LABELS AND PACKAGES
PRINCIPAL DISPLAY PANEL
Hydralazine Hydrochloride Tablets USP 10 mg 100s Label Text
NDC 50111-398-01
HydrALAZINE HYDROCHLORIDE Tablets USP 10 mg
Rx only
100 TABLETS
TEVA
PRINCIPAL DISPLAY PANEL
 |
Hydralazine Hydrochloride Tablets USP 25 mg 100s Label Text
NDC 50111-327-01
HydrALAZINE HYDROCHLORIDE Tablets USP 25 mg
Rx only
100 TABLETS
TEVA
PRINCIPAL DISPLAY PANEL
 |
Hydralazine Hydrochloride Tablets USP 50 mg 100s Label Text
NDC 50111-328-01
HydrALAZINE HYDROCHLORIDE Tablets USP 50 mg
Rx only
100 TABLETS
TEVA
PRINCIPAL DISPLAY PANEL
 |
Hydralazine Hydrochloride Tablets USP 100 mg 100s Label Text
NDC 50111-397-01
HydrALAZINE HYDROCHLORIDE Tablets USP 100 mg
Rx only
100 TABLETS
TEVA[1]
References
- ↑ "HYDRALAZINE HYDROCHLORIDE TABLET [PLIVA INC.]". Retrieved 10 March 2014.